Bio Solution Co Ltd
KOSDAQ:086820
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bio Solution Co Ltd
Accrued Liabilities
Bio Solution Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bio Solution Co Ltd
KOSDAQ:086820
|
Accrued Liabilities
₩505.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Accrued Liabilities
₩191.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Accrued Liabilities
₩449.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Accrued Liabilities
₩375m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
18%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Accrued Liabilities
₩462.2m
|
CAGR 3-Years
36%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Accrued Liabilities
₩4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bio Solution Co Ltd
Glance View
Bio Solution Co. Ltd. engages in the development of cell therapy products and stem cell applied technologies based on tissue engineering and stem cell technologies. The company is headquartered in Seoul, Seoul and currently employs 97 full-time employees. The company went IPO on 2018-08-20. is a Korea based company mainly engaged in the manufacturing and distribution of cell therapy products. The firm manufactures and sells cell based cosmetic raw materials and therapeutics with background in somatic and stem cell technology. The Company’s major products include cosmetic raw material called stem water, which contains human stem cells has whitening and anti-wrinkling effects; as well as keratinocyte medication for severe burns and chondrocyte therapy product used to cure arthritis. The firm also researches and develops human tissue models for toxicity and efficacy testing using tissue engineering technology.
See Also
What is Bio Solution Co Ltd's Accrued Liabilities?
Accrued Liabilities
505.8m
KRW
Based on the financial report for Sep 30, 2025, Bio Solution Co Ltd's Accrued Liabilities amounts to 505.8m KRW.
What is Bio Solution Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
21%
Over the last year, the Accrued Liabilities growth was 103%. The average annual Accrued Liabilities growth rates for Bio Solution Co Ltd have been 22% over the past three years , 21% over the past five years .
